Dr. Hella Kohlhof
Equibles does not estimate personal net worth.
About Dr. Hella Kohlhof
Immunic, Inc. reported in an 8-K filed December 21, 2023 that Dr. Hella Kohlhof was appointed Board Member for scientific management (CSO), effective January 1, 2024. Immunic, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunic, Inc. includes Dr. Daniel Vitt (CEO), Duane D. Nash (CEO), Duane Nash (CEO) and 7 others.
“Der Vorstand ist mit beigefügten Aufsichtsratsbeschluss erneut zum Mitglied des Vorstand der Gesellschaft bestellt worden, diesmal für den Zeitraum vom 01.01.2024 bis zum 31.12.2026 ("Laufzeit").”
Affiliation history
-
Immunic, Inc. (IMUX)
Proxy statement
CurrentStart not stated–present
Last confirmed May 29, 2026
Company network
Leadership on record at Immunic, Inc.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel